BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28416487)

  • 21. Ultrahigh resolution lipid mass spectrometry imaging of high-grade serous ovarian cancer mouse models.
    Ma X; Botros A; Yun SR; Park EY; Kim O; Park S; Pham TH; Chen R; Palaniappan M; Matzuk MM; Kim J; Fernández FM
    Front Chem; 2023; 11():1332816. PubMed ID: 38260043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multivariate statistical identification of human bladder carcinomas using ambient ionization imaging mass spectrometry.
    Dill AL; Eberlin LS; Costa AB; Zheng C; Ifa DR; Cheng L; Masterson TA; Koch MO; Vitek O; Cooks RG
    Chemistry; 2011 Mar; 17(10):2897-902. PubMed ID: 21284043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers.
    Bae G; Berezhnoy G; Koch A; Cannet C; Schäfer H; Kommoss S; Brucker S; Beziere N; Trautwein C
    Front Mol Biosci; 2023; 10():1158330. PubMed ID: 37168255
    [No Abstract]   [Full Text] [Related]  

  • 24. Intra-Tumoral Nerve-Tracing in a Novel Syngeneic Model of High-Grade Serous Ovarian Carcinoma.
    Barr JL; Kruse A; Restaino AC; Tulina N; Stuckelberger S; Vermeer SJ; Williamson CS; Vermeer DW; Madeo M; Stamp J; Bell M; Morgan M; Yoon JY; Mitchell MA; Budina A; Omran DK; Schwartz LE; Drapkin R; Vermeer PD
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Super-Enhancer-Driven RAE1 Shows Higher Protein Levels in Tumor Compared to Adjacent Nonmalignant Stroma in High-Grade Serous Ovarian Cancer Patients.
    Berkel C; Cacan E
    Reprod Sci; 2023 Aug; 30(8):2397-2400. PubMed ID: 36810690
    [No Abstract]   [Full Text] [Related]  

  • 26. Machine Learning Reveals Lipidome Remodeling Dynamics in a Mouse Model of Ovarian Cancer.
    Bifarin OO; Sah S; Gaul DA; Moore SG; Chen R; Palaniappan M; Kim J; Matzuk MM; Fernández FM
    J Proteome Res; 2023 Jun; 22(6):2092-2108. PubMed ID: 37220064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mass Spectrometry Imaging of Lumpectomy Specimens Deciphers Diacylglycerols as Potent Biomarkers for the Diagnosis of Breast Cancer.
    Mondal S; Sthanikam Y; Kumar A; Nandy A; Chattopadhyay S; Koner D; Rukmangadha N; Narendra H; Banerjee S
    Anal Chem; 2023 May; 95(20):8054-8062. PubMed ID: 37167069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of aberrantly expressed long non-coding RNAs in ovarian high-grade serous carcinoma cells.
    Nakashima K; Sato S; Tamura I; Hayashi-Okada M; Tamehisa T; Kajimura T; Sueoka K; Sugino N
    Reprod Med Biol; 2020 Jul; 19(3):277-285. PubMed ID: 32684827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population.
    McCloskey CW; Goldberg RL; Carter LE; Gamwell LF; Al-Hujaily EM; Collins O; Macdonald EA; Garson K; Daneshmand M; Carmona E; Vanderhyden BC
    Front Oncol; 2014; 4():53. PubMed ID: 24672774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Tumor Antigens and Immune Subtypes of High-grade Serous Ovarian Cancer for mRNA Vaccine Development.
    Wu Y; Li Z; Lin H; Wang H
    J Cancer; 2023; 14(14):2655-2669. PubMed ID: 37779866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic profile of borderline ovarian tumors in the Lebanese population by whole-exome sequencing.
    Feghaly I; Kourie H; Moubarak M; Chouery E; Mehawej C; Jalkh N; Atallah D
    Int J Gynaecol Obstet; 2023 Sep; 162(3):1027-1032. PubMed ID: 37185951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Stratification of High-Grade Ovarian Serous Carcinoma Using a Panel of Six Biomarkers.
    Kamble SC; Sen A; Dhake RD; Joshi AN; Midha D; Bapat SA
    J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30857227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of the Galectin-8 Immunohistochemical Profile in Ovarian Cancer.
    Avădănei ER; Căruntu ID; Amalinei C; Păvăleanu I; Giușcă SE; Rusu A; Lozneanu L
    Biomedicines; 2024 Jan; 12(2):. PubMed ID: 38397905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening and identification of serum exosomal protein ZNF587B in liquid biopsy for ovarian cancer diagnosis.
    Li H; Sui T; Chen X; Gu Y; Luo X; Liu Y; He Q
    Am J Cancer Res; 2024; 14(4):1904-1913. PubMed ID: 38726286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment.
    Zhu Y; Ferri-Borgogno S; Sheng J; Yeung TL; Burks JK; Cappello P; Jazaeri AA; Kim JH; Han GH; Birrer MJ; Mok SC; Wong STC
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review.
    Liberto JM; Chen SY; Shih IM; Wang TH; Wang TL; Pisanic TR
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uterine washings as a novel method for early detection of ovarian cancer: Trials and tribulations.
    Sia TY; Yaari Z; Feiner R; Smith E; Da Cruz Paula A; Selenica P; Doddi S; Chi DS; Abu-Rustum NR; Levine DA; Weigelt B; Fleisher M; Ramanathan LV; Heller DA; Long Roche K
    Gynecol Oncol Rep; 2024 Feb; 51():101330. PubMed ID: 38356691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-cell transcriptomics reveals the aggressive landscape of high-grade serous carcinoma and therapeutic targets in tumor microenvironment.
    Xu J; Lu W; Wei X; Zhang B; Yang H; Tu M; Chen X; Wu S; Guo T
    Cancer Lett; 2024 May; 593():216928. PubMed ID: 38714290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian cancer beyond imaging: integration of AI and multiomics biomarkers.
    Hatamikia S; Nougaret S; Panico C; Avesani G; Nero C; Boldrini L; Sala E; Woitek R
    Eur Radiol Exp; 2023 Sep; 7(1):50. PubMed ID: 37700218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The spatial structure of the tumor immune microenvironment can explain and predict patient response in high-grade serous carcinoma.
    Van Kleunen L; Ahmadian M; Post MD; Wolsky RJ; Rickert C; Jordan K; Hu J; Richer JK; Marjon NA; Behbakht K; Sikora MJ; Bitler BG; Clauset A
    bioRxiv; 2024 Jan; ():. PubMed ID: 38352574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.